Pharma Journalist -

Leap Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the Company orphan drug designation for DKN-01 for the treatment of gastric and…
Read More...

RELIEF THERAPEUTICS Holding AG and its U.S. partner, NeuroRx, Inc. announced that Houston Methodist Hospital is participating in their Phase 2 clinical trial evaluating RLF-100 as a…
Read More...

Illumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use…
Read More...

DelMar Pharmaceuticals, Inc. and Adgero Biopharmaceuticals Holdings, Inc. announced the companies have entered into a definitive merger agreement pursuant to which DelMar, a…
Read More...

AbbVie and Genmab A/S announced that AbbVie and Genmab have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab's early-stage investigational…
Read More...

BryoLogyx Inc. announced it has entered into two agreements with Neurotrope, Inc. to acquire Neurotrope’s preclinical data package and drug product for use of bryostatin-1 in an…
Read More...

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval of the label extension for KALYDECO (ivacaftor) to include the treatment of children and…
Read More...

Pfizer Inc. announced positive top-line results from the Phase 3 JADE TEEN study of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients 12 to…
Read More...

UbiVac, Inc. announced it has entered into a clinical trial collaboration with Bristol Myers Squibb to evaluate the safety, tolerability, and preliminary efficacy of UbiVac’s…
Read More...

Lyvgen, a biopharmaceutical company focused on developing innovative immuno-oncology therapeutics, announces that it has entered into a clinical trial collaboration agreement with a…
Read More...